OnKure Funding & Investors
Boulder, CO
OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.
onkuretherapeutics.comTotal Amount Raised: $406,493,888
OnKure Funding Rounds
Post Ipo Equity
$65,000,000
Post Ipo Equity Investors
Surveyor CapitalSamsara BioCapitalAcorn BioventuresDeep Track CapitalVestal Point CapitalCormorant Asset ManagementPerceptive AdvisorsSeries C
$54,000,000
Series C Investors
Surveyor CapitalAcorn BioventuresCormorant Asset ManagementPerceptive AdvisorsDeep Track CapitalSamsara BioCapitalBlackRockPost Ipo Equity
$55,000,000
Post Ipo Secondary
$20,000,000
Series B
$56,649,181
Series B Investors
Acorn BioventuresCormorant Asset ManagementPerceptive AdvisorsSamsara BioCapitalSurveyor CapitalIPO
Unknown
Series B
$95,000,000
Series B Investors
AbingworthNovo VenturesAisling CapitalRock Springs CapitalRiverVest Venture ManagementAmzak Health InvestorsLundbeckfonden VenturesNEA - New Enterprise AssociatesPappas CapitalChiesi VenturesDebt Financing
$2,000,000
Series A
$50,000,000
Series A Investors
NEA - New Enterprise AssociatesLundbeckfonden VenturesRiverVest Venture ManagementPappas CapitalSeries A
$7,000,000
Series A Investors
Delian CapitalOnKure managementSeed
$495,000
Seed
$599,705
Grant
$250,000
Pre Seed
$499,985
Funding info provided by Diffbot.